.png)
NAFDAC Updates Pharmaceutical Ceiling List, Reinforcing Local Manufacturing Requirements
Regulatory Update | November 2026
Nigeria is taking another step toward strengthening domestic pharmaceutical manufacturing, with an updated measure affecting the registration of imported pharmaceutical products.
On 28 October 2026, the National Agency for Food and Drug Administration and Control (NAFDAC) announced an update to its Pharmaceutical Ceiling List. Under the announcement:
NAFDAC will no longer accept new registration applications for imported pharmaceutical products on the updated list
Renewals for existing registrations will be processed through NAFDAC's Five Plus Five (5+5) policy pathway
Applicants must submit a blueprint or plan for transitioning the affected product to local manufacturing
This is especially relevant for international pharmaceutical manufacturers, Nigerian importers, and marketing authorisation holders seeking to establish or maintain access to the Nigerian market.
Understanding the Updated Ceiling List
The Ceiling List is part of Nigeria's broader strategy to encourage domestic pharmaceutical production and reduce reliance on imported finished products where local manufacturing capacity exists. It identifies products for which local manufacturing is being prioritised, supporting industry growth while improving the availability and accessibility of medicines.
The October announcement draws a clear line between new applications and renewals:
Situation | What Applies |
New registration of an imported product on the list | No longer accepted |
Renewal of an existing registration for a listed product | Processed via the 5+5 pathway, with a local manufacturing transition plan |
Scope matters: the restriction applies to products on the Ceiling List. It is not a blanket ban on all imported pharmaceutical products in Nigeria.
What Is the 5+5 Policy?
NAFDAC's Five Plus Five policy encourages international manufacturers to establish local production in Nigeria either by building local facilities or by partnering with qualified Nigerian pharmaceutical companies. It gives companies a framework to maintain regulatory access while moving toward local production.
Under NAFDAC's original framework:
Product registration is initially valid for five years
By the end of the fourth year, companies are expected to submit draft blueprints outlining local manufacturing arrangements or partnerships
At renewal, companies with verifiable plans may receive a further five-year registration, during which NAFDAC monitors progress toward local production
The policy also recognises that not every product can be manufactured locally right away; the transition focuses on products where domestic manufacturers have the capacity, or where partnerships can build it. The October announcement reinforces the policy's relevance for products on the updated list.
What This Means for International Manufacturers
When planning Nigerian market entry or registration strategy, the first step is to check whether your product appears on the updated list. If it does, new imported-product applications will not be accepted.
For existing registrations, renewal planning must now account for the 5+5 pathway and the expectation of a local manufacturing transition blueprint. That may mean reassessing current market-access arrangements and weighing whether local partnerships or domestic investment are commercially and operationally feasible.
It also underscores a wider lesson: coordinate regulatory, manufacturing, and commercial decisions early, rather than waiting until renewal approaches.
What Companies Should Do Now
1. Check the updated Ceiling List: Confirm whether your active ingredient, dosage form, and product category are included. Use the latest official list, not previous versions.
2. Review existing registrations: Identify products that may be affected and map upcoming renewal dates.
3. Evaluate local manufacturing options: Consider partnerships with qualified Nigerian manufacturers or establishing local manufacturing arrangements for affected products.
4. Prepare a transition blueprint. If renewal is approaching, start building a practical plan for local production covering manufacturing capacity, technical requirements, investment, and implementation timelines.
5. Monitor further NAFDAC guidance. Watch for official clarification on the updated list, application procedures, and implementation expectations.
ARQon Insight
Nigeria remains an important pharmaceutical market in Africa, but market access increasingly requires manufacturers to consider the country's domestic manufacturing priorities.
NAFDAC's updated list reinforces the need to align product-registration strategy with local production policy. Market-entry planning now extends beyond obtaining an initial registration certificate; understanding which products are affected, assessing local manufacturing capacity, and identifying suitable Nigerian partners all feed into sound long-term regulatory and commercial decisions.
Key Takeaway
NAFDAC's announcement of 28 October 2026 marks an important development for imported pharmaceutical products on Nigeria's updated Ceiling List. New applications for affected imported products will no longer be accepted, while renewals will follow the 5+5 pathway, with a blueprint for migration to local manufacturing.
For international manufacturers and their Nigerian partners, early regulatory assessment and local manufacturing planning will be essential for continued market access.
In Nigeria, market access and local manufacturing strategy are now part of the same conversation.
How ARQon Can Support You
At ARQon, we support healthcare companies navigating regulatory requirements and market-entry considerations across African markets through:
Regulatory intelligence and monitoring
Registration support
Regulatory compliance guidance
Stay Ahead. Stay Compliant. Stay Informed. With ARQon Regulatory Intelligence.
Official Sources
NAFDAC Ceiling List, published 28 October 2026: https://nafdac.gov.ng/nafdac-ceiling-list/
NAFDAC Five Plus Five-Year Validity (Migration to Local Production), published 17 April 2019: https://nafdac.gov.ng/five-plus-five-year-validity-migration-to-local-production/
NAFDAC Modernisation and Foundation Laying of NAFDAC Regulatory Systems: Reflections on 2025: https://nafdac.gov.ng/media-parley-and-speech-modernisation-and-foundation-laying-of-nafdac-regulatory-systems-2018-date-reflections-on-2025/
Comments